Faes Farma, S.A. (FAE.MC)
EUR 3.47
(0.14%)
EUR 3.47
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 100.96 Million | 106.78 Million | 79.64 Million | 78.48 Million | 67.58 Million | 59.33 Million |
| Net Income | 91.69 Million | 89.5 Million | 83.21 Million | 73.37 Million | 64.02 Million | 51.8 Million |
| Depreciation & Amortization | 19.39 Million | 19.27 Million | 16.23 Million | 14.82 Million | 12.67 Million | 10.25 Million |
| Deferred income taxes | 6.57 Million | 9.75 Million | 3.38 Million | 4.53 Million | 4.54 Million | 5.75 Million |
| Stock-based compensation | 774 Thousand | 146 Thousand | - | - | - | - |
| Change in working capital | -16.97 Million | -11 Million | -26.91 Million | -29.53 Million | -25.02 Million | -11.3 Million |
| Other non-cash items | -491 Thousand | -886 Thousand | 7.11 Million | 19.82 Million | 15.9 Million | 8.59 Million |
| Investing Cash Flow | -97.35 Million | -92.17 Million | -83.48 Million | -25.78 Million | -34.03 Million | -19.55 Million |
| Investments in PPE | -102.19 Million | -80.94 Million | -59.41 Million | -25.72 Million | -21.4 Million | -12.66 Million |
| Acquisitions | -4.54 Million | 18.67 Million | -22.61 Million | 385 Thousand | -11.63 Million | 152 Thousand |
| Investment purchases | -8.83 Million | -21.5 Million | -1.88 Million | -600 Thousand | -1.39 Million | -7.11 Million |
| Sales/Maturities of investments | 18.21 Million | 2.82 Million | 1.88 Million | -385 Thousand | 4.43 Million | - |
| Other Investing Activities | 2.95 Million | -11.22 Million | -1.45 Million | 541 Thousand | -4.03 Million | 228 Thousand |
| Financing Cash Flow | -35.37 Million | -18.45 Million | -17.11 Million | -14.35 Million | -56.73 Million | -7.01 Million |
| Debt repayment | -3.34 Million | -2.62 Million | -1.45 Million | -2.48 Million | -43.92 Million | -1.06 Million |
| Dividends payments | -14.6 Million | -18.14 Million | -13.71 Million | -11.54 Million | -10.33 Million | -7.54 Million |
| Common Stock Repurchased | -17.68 Million | - | - | -92 Thousand | -2.83 Million | -1.58 Million |
| Common Stock Issuance | - | - | - | - | - | 1.06 Million |
| Other Financing Activities | 260 Thousand | 2.31 Million | -1.94 Million | 458 Thousand | 358 Thousand | 2.11 Million |
| Accounts receivables | 936 Thousand | -1.1 Million | -3.8 Million | -11.38 Million | -7.3 Million | -5.82 Million |
| Accounts payables | -1.43 Million | 1.18 Million | -6.86 Million | 4.67 Million | -7.53 Million | 6.7 Million |
| Inventory | -13.26 Million | -8.8 Million | -10.82 Million | -20.85 Million | -8.59 Million | -10.7 Million |
| Other working capital | -3.21 Million | -2.28 Million | -5.42 Million | -1.97 Million | -1.59 Million | 5.21 Million |
| Cash at beginning of period | 66.41 Million | 70.25 Million | 91.21 Million | 52.85 Million | 76.03 Million | 43.26 Million |
| Cash at end of period | 34.64 Million | 66.41 Million | 70.25 Million | 91.21 Million | 52.85 Million | 76.03 Million |
| Capital Expenditure | -102.19 Million | -80.94 Million | -59.41 Million | -25.72 Million | -21.4 Million | -12.66 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -31.76 Million | -3.84 Million | -20.95 Million | 38.35 Million | -23.18 Million | 32.76 Million |
| Free Cash Flow | -1.22 Million | 25.84 Million | 20.22 Million | 52.76 Million | 46.18 Million | 46.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.89 Million | 30.46 Million | 91.69 Million | 38.9 Million | 21.16 Million | 53 Million |
| Depreciation & Amortization | 10.07 Million | - | 19.39 Million | 9.96 Million | - | 9.43 Million |
| Deferred income taxes | - | - | 6.57 Million | -448 Thousand | - | - |
| Stock-based compensation | - | - | 774 Thousand | 774 Thousand | - | - |
| Change in working capital | -21.37 Million | - | -16.97 Million | -1.55 Million | - | -15.42 Million |
| Other non-cash items | -27.89 Million | -30.46 Million | -491 Thousand | 20.94 Million | -21.16 Million | 38.7 Million |
| Investing Cash Flow | -16.99 Million | - | -97.35 Million | -38.22 Million | - | -59.13 Million |
| Investments in PPE | -20.67 Million | - | -102.19 Million | -40.68 Million | - | -61.5 Million |
| Acquisitions | -480 Thousand | - | -4.54 Million | 71 Thousand | - | -4.61 Million |
| Investment purchases | -1.76 Million | - | -8.83 Million | - | - | - |
| Sales/Maturities of investments | 5.92 Million | - | 18.21 Million | 11.21 Million | - | 6.99 Million |
| Other Investing Activities | - | - | 2.95 Million | -8.83 Million | - | - |
| Financing Cash Flow | -14.03 Million | - | -35.37 Million | -10.13 Million | - | -25.24 Million |
| Debt repayment | -192 Thousand | - | -3.34 Million | -1.31 Million | - | -1.76 Million |
| Dividends payments | - | - | -14.6 Million | - | - | -14.6 Million |
| Common Stock Repurchased | - | - | -17.68 Million | -8.82 Million | - | -8.86 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.7 Million | - | 260 Thousand | - | - | - |
| Accounts receivables | -25.05 Million | - | 936 Thousand | 7.07 Million | - | -6.14 Million |
| Accounts payables | 15.44 Million | - | -1.43 Million | -9.01 Million | - | 7.58 Million |
| Inventory | -10.73 Million | - | -13.26 Million | 2.77 Million | - | -16.03 Million |
| Other working capital | -1.02 Million | - | -3.21 Million | -2.39 Million | - | -828 Thousand |
| Cash at beginning of period | 34.64 Million | - | 66.41 Million | 34.3 Million | - | 66.41 Million |
| Cash at end of period | 60.73 Million | - | 34.64 Million | 34.64 Million | - | 34.3 Million |
| Capital Expenditure | -20.67 Million | - | -102.19 Million | -40.68 Million | - | -61.5 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 26.08 Million | - | -31.76 Million | 346 Thousand | - | -32.11 Million |
| Free Cash Flow | 36.44 Million | - | -1.22 Million | 8.02 Million | - | -9.24 Million |
ELEK
SYNEX-R
ITNS
DMT
CPINV
SYNEX